PIK3CG and lung cancer: A growing body of evidence suggests that aberrant activation of the PI3K/AKT pathway promotes the development and progression of multiple human malignancies [65, 66], such as lung cancer [67], ovarian cancer [68], and oral squamous cell carcinoma [69].